Germ-free mice have become the gold standard for researchers focused on understanding the microbiome. Compared to conventio…
Alzheimer’s disease (AD) affects an estimated 24 million people worldwide. Although several medications have been FDA appro…
The development of immunodeficient mouse models has advanced our understanding of how cancer progresses and has drastically…
GemPharmatech is a leading provider of genetically engineered mouse models and preclinical services to global R&D commu…
Approximately 7% -9% of the global population suffers from autoimmune diseases. World-wide drug sales for the treatment of …
A Rapid NASH Model and its Application in Candidate Drug Screening for Metabolic Syndrome and Hepatic Steatosis
We will be in beautiful San Diego, CA from June 13-16, 2022, attending #BIO2022! Stop by our booth (#2527) an…
Our team will be attending Oxford Global’s Discovery Europe Summit in Berlin, Germany from June 9-10, 2022. S…
We are excited to announce that GemPharmatech will be New Orleans, LA attending the American Diabetes Association’s 82nd…